Physician profile
Daniel B Hoag
NPI 1255403853
$710.02
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.98 · 2020: $72.46 · 2021: $287 · 2022: $260.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $185.44 | 2021-2022 | |
| Abbott Laboratories | $134.30 | 2021-2022 | |
| Livanova USA, INC. | $117.51 | 2021 | |
| Novo Nordisk INC | $45.61 | 2019-2020 | |
| Topcon Healthcare Solutions, INC. | $44.98 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.89 | 2019 | |
| Boston Scientific Corporation | $25.46 | 2019-2020 | |
| Hologic Sales and Service, LLC | $18.51 | 2022 | |
| Abiomed | $17.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.79 | 2021 | |
| Lucid Diagnostics INC. | $16.72 | 2022 | |
| Glaxosmithkline, LLC. | $15.82 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.58 | 2021 | |
| Medtronic USA, INC. | $12.50 | 2019 | |
| Medtronic, INC. | $11.48 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.